Integrated outsourcing transforms and increases R&D productivity

Journal of Commercial Biotechnology

Volumn 19, Issue 4, 2013, Pages 49-54

  Levy, Henry ^a  

^a ACCENTURE   (United States)

Author keywords

Biotechnology; Integrated outsourcing; Pharmaceutical; Productivity; R D; Transform

Indexed keywords

BIOTECHNOLOGY; DRUG PRODUCTS; MATHEMATICAL TRANSFORMATIONS; PRODUCTIVITY;

ACCENTURE; PHARMACEUTICAL COMPANY; POTENTIAL VALUES; ROADMAP; SOURCING STRATEGIES;

OUTSOURCING;

CONFERENCE PAPER; DEVELOPMENT; DRUG INDUSTRY; ECONOMIC ASPECT; LEADERSHIP; PRODUCTIVITY;

EID: 84885405278     PISSN: 14628732     EISSN: 1478565X     Source Type: Journal    
DOI: 10.5912/jcb635     Document Type: Conference Paper

References (7)

1. Accenture Research, based on CMR's 2012 Pharmaceutical R&D Factbook, Thomas Reuters, and EvaluatePharma, 2013.
2. Approval is Nothing without Reimbursement: Why Pharmaceutical Companies Need a Value Management Operating Model, Accenture, 2013.
3. Tufts Center for the Study of Drug Development, November/December Impact Report, November 2012; http://csdd.tufts.edu/news/complete-story/pr-ir-nov-dec- 2012.
4. Accenture Technology Vision 2013-Every Business is a Digital Business executive summary, Accenture, 2013.
5. A New Era in Life Sciences: Cloud Computing Changes the Game, Accenture, 2013.
6. Clinical Data Interchange Standards Consortium. Mission statement. http://www.cdisc.org/missionand-principles
7. Pharma's Sharp Right Turn on R&D, Accenture, 2013.